Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 05:58 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Assessment of Opioid Analgesia in Sickle Cell
NCT00513864 · Children's National Research Institute · PHASE4 · withdrawn · last registry update 2014-12-23 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “lack of funding” | – | Registry record, Children's National Research Institute |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against SIGMAR1 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2015-12-15Results posted on the registry: University of Florida, Diphenhydramine + Pantoprazole (NCT02142712)
- 2015-10-06Also stopped (withdrawn): Emergency NGO Onlus, Best Supportive Care + Best Supportive Care + Amiodarone (NCT02307591)
- 2015-10-05Results posted on the registry: Hoffmann-La Roche, Drug cocktail + RO5185426 (NCT01001299)
- 2015-06-08Results posted on the registry: National Eye Institute (NEI), Dextromethorphan hydrobromide (NCT01441102)
- 2015-05-18Phase 3 first posted: Otsuka Pharmaceutical Development & Commercialization, Inc., AVP-786 (NCT02446132)
- 2015-05-13Phase 3 first posted: Otsuka Pharmaceutical Development & Commercialization, Inc., AVP-786 + Placebo (NCT02442765)
- 2015-05-13Phase 3 first posted: Otsuka Pharmaceutical Development & Commercialization, Inc., AVP-786-18 + Placebo (NCT02442778)
- 2015-04-28Results posted on the registry: Montefiore Medical Center, diphenhydramine/phenylephrine/cocoa; dextromethorophan; placebo + diphenhydramine/phenylephrine/cocoa; placebo; dextromethorphan (NCT02062710)
- 2015-03-31Results posted on the registry: Taichung Veterans General Hospital, Dextromethorphan hydrobromide (NCT02368093)
- 2014-12-04Phase 3 first posted: Emergency NGO Onlus, Best Supportive Care + Best Supportive Care + Amiodarone (NCT02307591)
- 2014-09-04Results posted on the registry: Mclean Hospital, Talwin Nx (NCT00125931)
- 2014-08-22Results posted on the registry: Repros Therapeutics Inc., Proellex + CYP1A2 probe (NCT00741468)
- 2014-08-21Results posted on the registry: Mclean Hospital, Pentazocine + Lorazepam (NCT00431184)
- 2014-08-08Phase 3 first posted: Duke University, Dextromethophan (NCT02212275)
- 2014-06-27Results posted on the registry: Bristol-Myers Squibb, Caffeine + Losartan (NCT01766050)
- 2014-04-23Results posted on the registry: Hugo W. Moser Research Institute at Kennedy Krieger, Inc., Dextromethorphan + Dextromethorphan (NCT00593957)
- 2014-04-23Also stopped (terminated): Hugo W. Moser Research Institute at Kennedy Krieger, Inc., Dextromethorphan + Dextromethorphan (NCT00593957)
- 2014-03-04Results posted on the registry: Aegerion Pharmaceuticals, Inc., atorvastatin + simvastatin (NCT00359281)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision